Related Experiment Video
Updated: Feb 5, 2026
High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
Published on: October 30, 2021
A functional in vitro assay for screening inhibitors of STAT5B phosphorylation
Elvin D de Araujo1, Pimyupa Manaswiyoungkul1, Fettah Erdogan1
1Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Rd N., Mississauga, Ontario L5L 1C6, Canada; Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario M5S 3H6, Canada.
Abstract:
Inhibition of STAT phosphorylation is recognized as a viable therapeutic strategy for disrupting tumorigenesis. Constitutive STAT phosphorylation is found with high frequency in a number of primary tumor types, while non-cancer cells exhibit low basal activity, providing an exploitable therapeutic window. STAT activation involves phosphorylation of the SH2 domain by a number of tyrosine kinases followed by STAT dimerization and translocation to the nucleus. By blocking the cognate binding site, STAT SH2-domain inhibitors can impede kinase-mediated de novo STAT phosphorylation. Assessing for inhibitors of STAT phosphorylation has previously been conducted exclusively in cellulo using Western blot analysis. However, while providing useful in cellulo efficacy, it is not possible to conclude that inhibition is due to a direct blockade of STAT protein. Here we developed a functional assay that directly reports the blockade of phosphorylation as a result of inhibitor interaction with STAT proteins. We have optimized reaction conditions for the functional assay and validated the assay against known STAT5B ligands, including peptides and small molecule inhibitors. As part of the study, we have also identified several sites of STAT5B phosphorylation by Abl kinase. This assay will serve to delineate the functional mechanism of STAT binders in vitro and deconvolute the mechanism of phospho-STAT inhibition observed in Western blot analysis.
Insights
This study introduces a novel functional assay to directly measure STAT phosphorylation inhibition by therapeutic compounds. This method differentiates direct STAT inhibition from indirect effects, aiding cancer drug development.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Signal Transducer and Activator of Transcription (STAT) phosphorylation is crucial for tumorigenesis.
- STAT activation, involving tyrosine kinase phosphorylation and dimerization, is a key therapeutic target.
- Current methods like Western blots lack direct evidence of STAT protein inhibition.
Purpose of the Study:
- To develop a functional in vitro assay for directly assessing STAT phosphorylation blockade.
- To validate the assay using known STAT5B ligands and identify phosphorylation sites.
- To elucidate the precise mechanism of STAT phosphorylation inhibitors.
Main Methods:
- Development and optimization of a novel functional assay for STAT phosphorylation.
- Validation of the assay with STAT5B ligands (peptides and small molecules).
- Identification of STAT5B phosphorylation sites targeted by Abl kinase.
Main Results:
- A functional assay was established to directly measure STAT phosphorylation inhibition.
- The assay was validated against known STAT5B inhibitors.
- Specific STAT5B phosphorylation sites targeted by Abl kinase were identified.
Conclusions:
- The developed assay provides a direct measure of STAT phosphorylation blockade by inhibitors.
- This tool enables in vitro mechanistic studies of STAT binders.
- It aids in deconvoluting observed phospho-STAT inhibition in Western blot analyses.
Related Concept Videos
01:02Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
01:52Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
01:23Dipeptidyl Peptidase 4 Inhibitors
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
02:45Functional Groups
01:25Antihypertensive Drugs: Direct Renin Inhibitors